Related Experiment Video
Updated: Aug 7, 2026

Expression, Purification, and Antimicrobial Activity of S100A12
Published on: May 13, 2017
S100A8 and S100A9 in inflammation and cancer
Christoffer Gebhardt1, Julia Németh, Peter Angel
1Division of Signal Transduction and Growth Control, German Cancer Research Center, Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
Abstract:
Calprotectin (S100A8/A9), a heterodimer of the two calcium-binding proteins S100A8 and S100A9, was originally discovered as immunogenic protein expressed and secreted by neutrophils. Subsequently, it has emerged as important pro-inflammatory mediator in acute and chronic inflammation. More recently, increased S100A8 and S100A9 levels were also detected in various human cancers, presenting abundant expression in neoplastic tumor cells as well as infiltrating immune cells. Although, many possible functions have been proposed for S100A8/A9, its biological role still remains to be defined. Altogether, its expression and potential cytokine-like function in inflammation and in cancer suggests that S100A8/A9 may play a key role in inflammation-associated cancer.
Related Concept Videos
Selectins
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
lncRNA - Long Non-coding RNAs
The Intrinsic Apoptotic Pathway

